These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16093964)

  • 1. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between sex hormones and the metabolic syndrome.
    Lunenfeld B
    Acta Biomed; 2010; 81 Suppl 1():79-84. PubMed ID: 20518195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?
    Kaplan SA; Meehan AG; Shah A
    J Urol; 2006 Oct; 176(4 Pt 1):1524-7; discussion 1527-8. PubMed ID: 16952672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular issues in hypogonadism and testosterone therapy.
    Shabsigh R; Katz M; Yan G; Makhsida N
    Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
    Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.
    Bojesen A; Høst C; Gravholt CH
    Mol Hum Reprod; 2010 Jun; 16(6):396-401. PubMed ID: 20231162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition, metabolic syndrome and testosterone in ageing men.
    Allan CA; Strauss BJ; McLachlan RI
    Int J Impot Res; 2007; 19(5):448-57. PubMed ID: 17554396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deficiency, diabetes, and the metabolic syndrome in men.
    Kalyani RR; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):226-34. PubMed ID: 17940444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative androgen deficiency in relation to obesity and metabolic status in older men.
    Chen RY; Wittert GA; Andrews GR
    Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
    Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
    J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
    Haider A; Gooren LJ; Padungtod P; Saad F
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):167-71. PubMed ID: 19472103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.